Portland, OR -- (SBWire) -- 06/13/2018 --The global rapid tests market generated $21,455 million in 2016, and is projected to reach $39,103 million by 2023, growing at a CAGR of 8.9% from 2017 to 2023. Rapid tests are diagnostic assays designed for use where preliminary screening tests need to be conducted. These tests are easy, quick, and provide specific results; hence, are used in settings with limited resources. Rapid tests are incorporated in diagnosis of different diseases and health conditions such as HIV, influenza, malaria, cancer, pregnancy & fertility, and others.
For More Info, Get Sample : https://www.researchbeam.com/rapid-tests-market/request-sample
The rapid tests market is expected to grow at a significant rate during the forecast period, owing to increase in awareness regarding early diagnosis of disease, prevalence of infectious diseases, and need for low cost as well as accurate diagnostic testing. In addition, growth in personalized care and increased promotional activities by manufacturers encourage the usage rapid tests, which further facilitate the growth of the market. However, stringent government regulations for the approval of rapid tests and recall of several products due to false results are expected to impede the market growth.
The global rapid tests market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into over-the-counter (OTC) rapid test product and professional rapid test product. By application, the market is classified into infectious disease, cardiology, oncology, pregnancy & fertility, toxicology, glucose monitoring, and others. According to end user, it is segmented as hospital & clinic, diagnostic laboratory, home care, and others. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the existing opportunities.
- The profiles and growth strategies of key players are thoroughly analyzed to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
Enquire About Report : https://www.researchbeam.com/rapid-tests-market/enquire-about-report
By Product
- OVER-THE-COUNTER (OTC) RAPID TEST PRODUCT
- PROFESSIONAL RAPID TEST PRODUCT
By Application
- Infectious Disease
- HPV
- Hepatitis
- Influenza
- Malaria
- HIV
- Others
- Cardiology
- Oncology
- Pregnancy & Fertility
- Toxicology
- Glucose Monitoring
- Others
By End User
- Hospital & Clinic
- Diagnostic Laboratory
- Home Care
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Also Request For Discount : https://www.researchbeam.com/rapid-tests-market/purchase-enquiry
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Akers Biosciences, Inc.
- Alere Inc. (Abbott Laboratories)
- Becton, Dickinson and Company
- Bio-rad Laboratories, Inc.
- Cepheid, Inc.
- Hologic, Inc.
- Meridian Bioscience, Inc.
- OraSure Technologies, Inc.
- Quidel Corporation
- Roche Diagnostics
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
- Abingdon Health
- ARKRAY, Inc.
- Biocom Diagnostics
- Biomerica, Inc.
- Demeditec Diagnostics GmbH
- Epitope Diagnostics Inc.
- NanoRepro AG.
- Randox Laboratories Ltd.
Table Of Content
- CHAPTER 1: INTRODUCTION
- CHAPTER 2: EXECUTIVE SUMMARY
- CHAPTER 3: MARKET OVERVIEW
- CHAPTER 4: RAPID TESTS MARKET, BY PRODUCT
- CHAPTER 5: RAPID TESTS MARKET, BY APPLICATION
- CHAPTER 6: RAPID TESTS MARKET, BY END USER
- CHAPTER 7: RAPID TESTS MARKET, BY REGION
- CHAPTER 8: COMPANY PROFILES
About Research Beam
We have a large database of quality and precise market research reports that will be very beneficial for your organization. Reports that we sell our authentic in nature and from reputed publishers, hence it can definitely help you with your growth opportunities. Research Beam will always make sure to bring most ethical and high quality reports. We value your relationship with us and look forward for a long term relation.
Contact Us
Global Head Quarters
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
+1 (800) 910-6452
help@researchbeam.com
Rapid Tests Market Reach $39,103 Million by 2023, Growing at a CAGR of 8.9%